BRWM
TFFP

B. Riley Wealth Management’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

B. Riley Wealth Management’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-572
Closed -$264K – 478
2020
Q3 		$264K Buy
+572
New +$161K 0.03% 314

Other funds holding TFFP

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
PM
Precept Management Dallas, Texas $126M AUM 36.77% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

B. Riley Wealth Management's TFFP Position: Q4 2020 in Review

B. Riley Wealth Management sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2020, closing a stake of 572 shares — an estimated $264K sold.

B. Riley Wealth Management first reported a position in TFFP in Q3 2020 and held it in 1 quarter. The position peaked at $264K in Q3 2020. 47 funds tracked by Wall St. Rank hold TFFP as of Q4 2020.

  • B. Riley Wealth Management reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • B. Riley Wealth Management sold 572 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2020, an estimated $264K.
  • B. Riley Wealth Management first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • B. Riley Wealth Management's TFF Pharmaceuticals, Inc. Common Stock position peaked at $264K in Q3 2020.
  • 47 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2020.

Based on B. Riley Wealth Management's 13F filing for Q4 2020, filed 11 Feb 2021.